SAN DIEGO--(BUSINESS WIRE)--Selva Therapeutics, Inc. (“Selva”) announced new preclinical data demonstrating SLV213, when given as a prophylactic or a treatment for SARS-CoV-2 infection, protects ...
The Ajinomoto Group is promoting greater wellness among people around the world with its Creating Shared Value (ASV) initiatives to get all of us to “Eat Well, Live Well”. The initiatives are linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback